Candesartan CAS 139481-59-7 Purity> 99.0% (HPLC) Factory
Ruifu Chemical Supply Candesartan Cilexetil Yapakatikati Ndi Kuyera Kwambiri
Candesartan Cilexetil CAS 145040-37-5
Candesartan CAS 139481-59-7
1-Chloroethyl Cyclohexyl Carbonate CAS 99464-83-2
Candesartan Cilexetil Wapakatikati Eethyl Ester C6 CAS 139481-41-7
Candesartan Cilexetil Wapakatikati CAS 139481-44-0
Trityl Candesartan Cilexetil CAS 170791-09-0
Dzina la Chemical | Candesartan |
Mawu ofanana ndi mawu | CV-11974;2-Ethoxy-1-[[2'- (1H-tetrazol-5-yl) [1,1'-biphenyl] -4-yl]methyl] -1H-Benzimidazole-7-Carboxylic Acid;3- [[2'- (1H-Tetrazol-5-yl) biphenyl-4-yl]methyl]-2-ethoxy-3H-Benzimidazole-4-Carboxylic Acid;Candesartan M1;Candesartan Cilexetil EP Impurity G |
Nambala ya CAS | 139481-59-7 |
Nambala ya CAT | Mtengo wa RF-PI1889 |
Stock Status | Mu Stock, Kupanga Kukula Mpaka Matani |
Molecular Formula | C24H20N6O3 |
Kulemera kwa Maselo | 440.45 |
Mtundu | Ruifu Chemical |
Kanthu | Zofotokozera |
Maonekedwe | Ufa Woyera |
Chizindikiritso-HPLC | Nthawi Yosunga Yofanana ndi Yokhazikika |
Chizindikiritso-IR | Zofanana ndi Standard |
Kuyera / Kusanthula Njira | >99.0% (HPLC) |
Melting Point | 183.0 ~ 185.0 ℃ |
Kutaya pa Kuyanika | <0.50% |
Chinyezi (KF) | <0.50% |
Zotsalira pa Ignition | <0.50% |
Zitsulo Zolemera | <20ppm |
Chidetso cha Munthu Payekha | <1.00% (HPLC) |
Zonse Zonyansa | <1.00% (HPLC) |
Refractive Index | n20/D 1.745~1.747 |
Test Standard | Enterprise Standard |
Kugwiritsa ntchito | API;Zochizira matenda oopsa |
Phukusi: Botolo, Aluminiyamu zojambulazo thumba, 25kg/Cardboard Drum, kapena malinga ndi lamulo la kasitomala
Mkhalidwe Wosungira:Sungani muzitsulo zosindikizidwa pamalo ozizira ndi owuma;Tetezani ku kuwala ndi chinyezi
Candesartan (CAS: 139481-59-7) ndi angiotensin II receptor antagonist ndi IC50 ya 0.26 nM.Zolinga: Angiotensin II Receptor candesartan amawonetsedwa pochiza matenda oopsa.Candesartan Cilexetil idavomerezedwa koyamba mu GB pa Apr 29, 1997, kenako kuvomerezedwa ndi US Food and Drug Administration (FDA) pa Juni 4, 1998, ndikuvomerezedwa ndi Pharmaceuticals and Medical Devices Agency of Japan (PMDA) pa Marichi 12, 1999. Idapangidwa ndi AstraZeneca, kenako idagulitsidwa ngati Atacand ndi AstraZeneca ku GB ndi US, ndikugulitsidwa ngati Blopress ndi Takeda ku JP.Candesartan Cilexetil ndi angiotensin II receptor blocker (ARB), imatchinga vasoconstrictor ndi aldosterone-secreting zotsatira za angiotensin II mwa kusankha kutsekereza kumangirira kwa angiotensin II ku AT1 receptor mu minofu yambiri, monga vascular smooth muscle ndi adrenal gland.Atacand amasonyezedwa pochiza matenda oopsa kwambiri kwa akuluakulu ndi ana a zaka 1 mpaka zaka 17, kulephera kwa mtima (NYHA class II-IV) ndipo amagwiritsidwa ntchito kuchepetsa imfa ya mtima ndi matenda a mtima.